Autor: "Pacciarini, Filippo" - OpacWWW

Skocz do pozycji: 1.

Czasopismo naukowe

Skocz do pozycji: 2.

Tytuł:: Homologous and Heterologous Boosting of the Chadox1-S1-S COVID-19 Vaccine With the SCB-2019 Vaccine Candidate: A Randomized, Controlled, Phase 2 Study.
Autorzy:: Costa Clemens SA; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.; Siena University, Siena, Italy.
Milan EP; Centro de Estudos e Pesquisa em Moléstias Infecciosas Ltda. (CEPCLIN), Natal, Brazil.
Sprinz E; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Neto JC; D'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Pacciarini F; Clover Biopharmaceuticals Inc., Cambridge, Massachusetts, USA.
Li P; Clover Biopharmaceuticals Inc., Cambridge, Massachusetts, USA.
Chen HL; Clover Biopharmaceuticals Inc., Cambridge, Massachusetts, USA.
Smolenov I; Clover Biopharmaceuticals Inc., Cambridge, Massachusetts, USA.
Pollard A; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.
Clemens R; International Vaccine Institute, Seoul, Republic of Korea.; Pokaż więcej
Źródło:: Open forum infectious diseases [Open Forum Infect Dis] 2022 Aug 16; Vol. 9 (8), pp. ofac418. Date of Electronic Publication: 2022 Aug 16 (Print Publication: 2022).
Typ publikacji:: Journal Article

Czasopismo naukowe

Informacja